Search
for
Sort by
Research 271–300 of 1000+
- Use of intramuscular triamcinolone acetonide in intermediate responders to janus kinase inhibition for alopecia areata: Case report
- Nouvelles thérapeutiques dans la prise en charge de l’alopécie androgénétique
- Tofacitinib for the Treatment of Three Immune-mediated Conditions in One Patient: Ulcerative Colitis, Pyoderma Gangrenosum, and Alopecia Areata
- Novedades terapéuticas en tricología
- Refractory dermatomyositis–systemic lupus erythematosus overlap syndrome and response to tofacitinib
- JAK Inhibitors for Treatment of Alopecia Areata
- Irish dermatologists’ experience with JAK inhibitors in alopecia areata
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- Jak inhibitors in the treatment of alopecia areata - a literature review
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Short-term malignancy risk of JAK inhibitors in severe alopecia areata: a multicenter cohort study
- “<i>Nomen Omen</i>: The Myth of God Janus”
- Screening for latent infectious disease in patients with alopecia areata before initiating JAK inhibitors therapy: a single-center real-world retrospective study
- JAK kinase pathway inhibitor drugs in patients with moderate-to-severe alopecia: a real-world experience
- INIBIDORES DA JANUS QUINASE PARA O TRATAMENTO DA ALOPECIA AREATA
- British Association of Dermatologists living guideline for managing people with alopecia areata 2024
- The Efficacy of Baricitinib as a Treatment Option for Alopecia, In Terms of Promoting Hair Regrowth and Improving Patient Reported Outcomes
- Uncommon Presentation of Pityriasis Rubra Pilaris of the Scalp: Clinical, Trichoscopic, and Histopathologic Features and Review of the Literature
- Assessing Alopecia Areata Management in Poland: Challenges in Medical Practices and Patient Care
- Considerations for the Treatment Strategy of Relapse After Tofacitinib Therapy in Alopecia Areata
- Comparative Efficacy and Safety of Baricitinib Against Traditional Therapies in Severe Alopecia Areata: A Retrospective Cohort Study
- Effectiveness of oral tofacitinib treatment on patients with moderate‐to‐severe alopecia areata in Iran
- Diagnostic Challenges and Treatment Strategies in Neutrophilic Cicatricial Alopecias: A Narrative Review from Conventional Therapies to New Therapeutic Targets
- COLLAB: A Global Survey of Clinical and Laboratory Assessment in Alopecia Areata by Hair Specialists
- Dissecting Cellulitis of the Scalp: Linking Pathogenesis to Therapy
- Case Report: Baricitinib improved alopecia areata in a pediatric patient with atopic dermatitis
- Repigmentation Competence in Vitiligo: Integrating Immune, Regulatory, Regenerative, and Microenvironmental Axes
- Systemic Treatment of Moderate to Severe Alopecia Areata in Adults: Updated Australian Expert Consensus Statement
- Upadacitinib for Alopecia Areata in Different Backgrounds: A Case Series
- Successful Treatment of Severe Alopecia Areata With Oral or Topical Tofacitinib.